Bicocca Open Archive

Logo unimib boa
GERUSSI, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.371
EU - Europa 2.780
AS - Asia 930
SA - Sud America 18
AF - Africa 8
Totale 8.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.345
IT - Italia 837
DE - Germania 527
SG - Singapore 434
SE - Svezia 401
IE - Irlanda 334
RU - Federazione Russa 287
CN - Cina 206
GB - Regno Unito 176
HK - Hong Kong 141
IN - India 40
FI - Finlandia 32
NL - Olanda 29
FR - Francia 28
CA - Canada 24
VN - Vietnam 23
MY - Malesia 19
BE - Belgio 18
ID - Indonesia 18
UA - Ucraina 18
AT - Austria 16
DK - Danimarca 16
BR - Brasile 11
CZ - Repubblica Ceca 10
IL - Israele 10
SK - Slovacchia (Repubblica Slovacca) 8
TR - Turchia 8
IR - Iran 7
LT - Lituania 7
ES - Italia 6
PL - Polonia 6
PT - Portogallo 5
JP - Giappone 4
MM - Myanmar 4
RO - Romania 4
RS - Serbia 4
AR - Argentina 3
GR - Grecia 3
KR - Corea 3
NO - Norvegia 3
PK - Pakistan 3
SC - Seychelles 3
TW - Taiwan 3
CH - Svizzera 2
EG - Egitto 2
GH - Ghana 2
IQ - Iraq 2
LU - Lussemburgo 2
PE - Perù 2
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MN - Mongolia 1
MX - Messico 1
PA - Panama 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 8.107
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.272
Frankfurt am Main 469
Singapore 380
Fairfield 361
Dublin 318
Milan 304
Chandler 292
Wilmington 265
Ashburn 182
Santa Clara 171
Woodbridge 166
New York 145
Hong Kong 134
Houston 129
Seattle 126
Cambridge 118
Chicago 100
London 99
Princeton 98
Shanghai 69
Dearborn 66
Altamura 46
Lawrence 46
Rome 38
Boardman 31
Helsinki 27
San Diego 26
Beijing 21
Florence 21
Monza 20
Pune 20
Jacksonville 19
Jakarta 18
Los Angeles 18
Brussels 17
Penang 16
Guangzhou 14
Toronto 14
Bari 13
Nanjing 13
Turin 13
Vienna 12
Mumbai 11
Andover 10
Lissone 10
Munich 10
Bologna 9
Brno 9
Fremont 9
Dong Ket 8
Padova 8
São Paulo 8
Dongguan 7
Modena 7
Naples 7
Bratislava 6
Central 6
Dallas 6
Hangzhou 6
Jinan 6
Kocaeli 6
Paris 6
Somma Vesuviana 6
Udine 6
Amsterdam 5
Cagliari 5
Carate Brianza 5
Delmar 5
Desio 5
Genoa 5
Huizen 5
Lappeenranta 5
Lisbon 5
Marietta 5
Moscow 5
Sacramento 5
Shenyang 5
Washington 5
Appiano Gentile 4
Atlanta 4
Castiglione del Lago 4
Council Bluffs 4
Hebei 4
Hefei 4
Kruševac 4
Meda 4
Norwalk 4
Quanzhou 4
Rimini 4
Romola 4
Treviglio 4
Zhengzhou 4
Athens 3
Bergamo 3
Birmingham 3
Brescia 3
Changsha 3
Chioggia 3
Conversano 3
Cossato 3
Totale 6.044
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 421
Better end points needed in primary sclerosing cholangitis trials 219
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 217
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 207
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 192
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 191
Precision medicine in primary biliary cholangitis 186
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 183
A second update on mapping the human genetic architecture of COVID-19 180
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 177
Risk stratification in primary sclerosing cholangitis 172
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 169
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 167
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 165
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 163
Mapping the human genetic architecture of COVID-19 163
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 162
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 161
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 161
New Therapeutic Targets in Autoimmune Cholangiopathies 156
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 154
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 154
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 149
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 149
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 144
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 140
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 137
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis 129
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 128
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 126
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 125
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 121
The immunobiology of female predominance in primary biliary cholangitis 119
The application of artificial intelligence in hepatology: A systematic review 112
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 106
Cost of illness of Primary Biliary Cholangitis - a population-based study 105
Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis 103
Gender differences in liver disease and the drug-dose gender gap 102
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 99
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 97
The role of ethnicity in autoimmune hepatitis 92
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 87
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 86
DISSECTING THE GENETIC ARCHITECTURE OF AUTOIMMUNITY: A SPOTLIGHT ON PRIMARY BILIARY CHOLANGITIS 86
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All 84
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 82
Elevated baseline igg is a risk factor for on-treatment flares of autoimmune hepatitis in patients in biochemical remission 78
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 77
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 74
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group 70
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 63
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 62
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 59
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 58
Artificial intelligence for precision medicine in autoimmune liver disease 55
Editorial: liver transplantation for primary biliary cholangitis–the need for timely and more effective treatments 54
Artificial Intelligence and liver: Opportunities and barriers 53
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 52
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 50
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] 50
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities 48
X marks the spot in autoimmunity 48
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 47
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 45
Genetics of Primary Biliary Cholangitis 42
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 41
The Role of Epigenetics in Primary Biliary Cholangitis 40
Open challenges in the management of autoimmune hepatitis 38
GWAS and autoimmunity: What have we learned and what next 37
The genetic architecture of primary biliary cholangitis 37
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 36
Primary Sclerosing Cholangitis 34
Bacterascites confers poor patient prognosis beyond MELD prediction 31
MEDTEC students against coronavirus: Investigating the role of hemostatic genes in the predisposition to COVID-19 severity 28
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA 27
Genetics of Autoimmune Liver Diseases 26
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 23
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 23
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 22
NON ADHERENCE TO AASLD - EASL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA DOES NOT TRANSLATE INTO WORSE OUTCOMES 22
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 20
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase 20
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 17
Incomplete normalization of transaminases at 18 months is the most important predictor for failure of biochemical response in autoimmune hepatitis 17
Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis 16
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 15
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase 14
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 13
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 13
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study 13
Primary Biliary Cholangitis 11
Black Ethnicity Affects the Clinical Presentation and Outcome in Autoimmune Hepatitis 11
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis 11
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 10
The impact of geographical region on outcomes of patients with primary biliary cholangitis from western Europe 10
EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) 9
Cost of Illness of Primary Biliary Cholangitis in Lombardia 9
Totale 8.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020755 0 0 0 0 105 117 142 109 115 92 52 23
2020/20211.525 34 29 276 66 122 205 170 223 102 85 119 94
2021/20221.051 107 104 160 108 79 61 43 69 48 25 85 162
2022/20231.850 172 440 148 141 236 245 86 90 112 64 70 46
2023/20241.644 49 59 75 161 187 328 207 37 76 172 40 253
2024/20251.370 248 398 218 186 320 0 0 0 0 0 0 0
Totale 8.607